AstraZeneca CEO Faces Shareholder Backlash on Pay

(Bloomberg) -- AstraZeneca Plc could face a shareholder revolt over its chief executive officer’s pay package this month after the U.K. Investment Association recommended investors vote against it,...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.